Santa Casa de São Paulo, School of Medical Sciences - São Paulo (SP), Brazil.
Secretaria de Estado da Saúde de São Paulo, Butantan Institute - São Paulo (SP), Brazil.
Rev Bras Epidemiol. 2024 Aug 19;27Suppl 1(Suppl 1):e240010.supl.1. doi: 10.1590/1980-549720240010.supl.1. eCollection 2024.
To analyze the experiences of transgender women and travestis regarding the use of hormones for body changes without a medical prescription.
This is a cross-sectional, quantitative and qualitative study, using data from "TransOdara", which estimated the prevalence of Sexually Transmitted Infections in transgender women and travestis recruited through Respondent-Driven Sampling, between December 2019 and July 2021, in São Paulo, Campo Grande, Manaus, Porto Alegre, and Salvador, Brazil. The main outcome was: use of hormones without medical prescription and associated risk factors. Descriptive analysis, mixed univariate logistic regression models, and semi-structured interviews were carried out.
Of the 1,317 recruited participants, 85.9% had already used hormones. The current use of hormones was reported by 40.7% (536) of them. Of those who were able to inform the place where they obtained them, 72.6% (381/525) used them without a medical prescription. The variables associated with the outcome were: current full-time sex work (OR 4.59; 95%CI 1.90-11.06) or in the past (OR 1.92; 95%CI 1.10-3.34), not having changed their name (OR 3.59; 95%CI 2.23-5.76), not currently studying (OR 1.83; 95%CI 1.07-3.13), being younger (OR 2.16; 95%CI 1.31-3.56), and having suffered discrimination at some point in life for being a transgender women and travestis (OR 0.40; 95%CI 0.20-0.81).
The use of nonprescribed hormones is high among transgender women and travestis, especially among those who are younger, did not study, have not changed their name, and with a history of sex work. This use is related to the urgency for gender transition, with excessive use and damage to health.
分析跨性别女性和跨性别者在没有处方的情况下使用激素改变身体的经历。
这是一项横断面、定量和定性研究,使用了 2019 年 12 月至 2021 年 7 月期间通过应答驱动抽样招募的来自巴西圣保罗、坎波格兰德、马瑙斯、阿雷格里港和萨尔瓦多的跨性别女性和跨性别者的“TransOdara”数据来估计性传播感染的患病率。主要结果是:未经处方使用激素和相关的危险因素。进行了描述性分析、混合单变量逻辑回归模型和半结构访谈。
在招募的 1317 名参与者中,85.9% 已经使用过激素。目前有 40.7%(536 人)报告正在使用激素。在能够告知他们获取激素的地方的人中,72.6%(381/525)是未经处方使用的。与结果相关的变量包括:目前全职性工作(OR 4.59;95%CI 1.90-11.06)或过去从事性工作(OR 1.92;95%CI 1.10-3.34)、未改名(OR 3.59;95%CI 2.23-5.76)、目前不学习(OR 1.83;95%CI 1.07-3.13)、年龄较小(OR 2.16;95%CI 1.31-3.56)以及在生活中的某个时刻因跨性别女性和跨性别者身份而遭受歧视(OR 0.40;95%CI 0.20-0.81)。
跨性别女性和跨性别者中未经处方使用激素的情况很高,尤其是那些年龄较小、未接受教育、未改名且有性工作史的人。这种使用与性别过渡的紧迫性有关,存在过度使用和健康损害的风险。